BioPharma Credit PLC
BOPCF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $1,016,738 | $1,080,567 | $1,046,705 | $1,094,269 |
| - Cash | $4,305 | $5,620 | $37,144 | $135,053 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1,012,433 | $1,074,947 | $1,009,561 | $959,216 |
| Revenue | $77,152 | $45,312 | $79,145 | $57,221 |
| % Growth | 70.3% | -42.7% | 38.3% | – |
| Gross Profit | $83,779 | $57,552 | $79,145 | $57,221 |
| % Margin | 108.6% | 127% | 100% | 100% |
| EBITDA | $0 | -$71,838 | $71,838 | -$7 |
| % Margin | 0% | -158.5% | 90.8% | -0% |
| Net Income | $72,783 | $50,340 | $71,838 | $37,523 |
| % Margin | 94.3% | 111.1% | 90.8% | 65.6% |
| EPS Diluted | 0.063 | 0.042 | 0.058 | 0.029 |
| % Growth | 50.7% | -27.2% | 100.3% | – |
| Operating Cash Flow | $33,756 | $64,269 | $47,643 | $92,776 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | $33,756 | $64,269 | $47,643 | $92,776 |